Either Zuconni misspoke or, he communicated direct
Post# of 146343
I think is the former rather than the latter. However, it does not matter much as the MRI's are showing improvement.
Of course, CTC count would be very valuable additional information.
We need to remember that a REDUCTION on the CTC count is by itself already a huge gain. It means life extension, what any Oncology drug tries to achieve.
Until there is a cure.
That is why the 14 week time-lapse for patient #1 is so #%#x#XX# important !!! The patient is having her life extended by Leronlimab in a significant amount
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)